Back to search results

AR/VR for Pain in Kidney Stone Patients

This study is looking at whether using a commercial AR/VR headset with a calming app can help reduce pain for patients who come to the emergency department (ED) with renal colic (kidney stone pain). You would either receive standard pain medication alone, or standard pain medication plus the AR/VR headset. The study aims to enroll 92 adults aged 18 and older who have a history of kidney stones and are experiencing moderate to severe pain. Researchers will measure your pain level 60 minutes after treatment to see if the AR/VR headset helps more than standard care alone. The current status of this study is unclear.

Study design
This study is interventional and will randomly assign participants to one of two groups. It plans to enroll 92 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your pain level will be measured at 60 minutes after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07070401

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

Recruiting
NAAges 18+InterventionalTreatment
Community Medical Center, Toms River, NJ
~92 participants
Updated 2025-07-17 on ClinicalTrials.gov
What's tested:Commercial AR/VR Headset with Calming AppPharmacologic Standard of Care Alone

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
60 Minute Pain Level
Measured over 60 minutes

Conditions

Renal Colic
Kidney Stones, Urolithiasis, Hypocitraturia

Explore related trials

Nephrolithiasis

Where it's being run

1 sites across 1 states
New Jersey1

Study leadership

  • Chris Delmaestro, DO · PRINCIPAL_INVESTIGATOR · Rutgers RWJBH Community Medical Center

Who to contact

Greg Neyman, MD
[email protected]
732.557.3242
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient self-reported history of nephrolithiasis
Subjective history suggesting that current presentation is similar to past presentations of nephrolithiasis (character, quality, location, intensity of pain; previous surgical intervention or lithotripsy)
Patients with self-reported moderate to severe pain on the visual pain scale determined as greater than 5/10
Normal vital signs (afebrile)
Agreeable to informed consent as dictated by IRB and local practice
No contraindications to standard therapy (ie fluids, NSAIDs, opioids, etc.)
Compliance with the virtual reality treatment
Keeps the headset on for the duration of the experience
Understands the instructions

Exclusion

Age \< 18 years
Pregnant
Individuals with chronic pain conditions such as fibromyalgia (chronic pain may confound results, as patients may have higher than baseline pain levels affecting their response to medications)
Individuals with severe anxiety or claustrophobia
Individuals with severe motion sickness or previous episodes of motion sickness due to VR (those who may not react well to the VR experience)
Individuals with GFR\<60 or previous documented diagnosis of CKD as they may not be suitable candidate for traditional analgesia
Individuals with previous opioid dependence
Requirement of immediate surgery (obstructing calculi with concomitant urinary tract infection)
Patients with diagnoses meeting admission criteria (sepsis, MI)
Audio/visual impairment (unable to appreciate stimuli provided by the headset)
Patients administered opiates as the first line pain control medication will not be included in final data collection, as opioid administration may result in difficulty consenting and understanding the study protocol / design

What this trial measures

  • 60 Minute Pain Level60 minutes

    Pain Level Change 60 minutes after enrollment, utilizing a 0-10 subjective score